Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PGM5 antisense RNA 1 (PGM5-AS1) is a human long non-coding RNA gene located on chromosome 9 (reverse strand)[1]. It belongs to the lncRNA class and acts as an antisense RNA relative to the protein-coding gene PGM5. Evidence indicates that PGM5-AS1 may function as a tumor suppressor, particularly in colorectal cancer, where its reduced expression is associated with increased tumor cell growth and proliferation in cellular and animal models. Conversely, higher PGM5-AS1 levels have sometimes been associated with poor prognosis, suggesting complex, context-dependent roles in cancer progression. It is being investigated as a potential prognostic biomarker for some cancer types, but there are no current therapeutic drugs targeting PGM5-AS1 or clinical safety concerns described in the literature[2][4][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PGM5 antisense RNA 1 (PGM5-AS1).